Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-09 4:58 pm Purchase | 13G | IDEAL POWER INC IPWR | HIRSCHMAN ORIN | 246,457 4.5% | 46,581 (+23.30%) | View |
2021-02-04 06:30 am Purchase | 13G | NLS PHARMACEUTICS LTD WT PUR C NLSPW | HIRSCHMAN ORIN | 920,000 7.8% | 920,000 (New Position) | View |
2021-02-04 06:30 am Sale | 13G | OCEAN BIO CHEM INC OBCI | HIRSCHMAN ORIN | 383,159 4.04% | -335,397 (-46.68%) | View |
2021-01-28 07:49 am Sale | 13G | ANNOVIS BIO INC ANVS | HIRSCHMAN ORIN | 328,358 4.76% | -170,439 (-34.17%) | View |
2021-01-25 4:20 pm Purchase | 13G | ALLENA PHARMACEUTICALS COM ALNAQ | HIRSCHMAN ORIN | 4,000,000 8% | 4,000,000 (New Position) | View |
2021-01-20 07:20 am Purchase | 13G | EVOKE PHARMA INC EVOK | HIRSCHMAN ORIN | 1,700,000 5.3% | 1,700,000 (New Position) | View |
2021-01-19 10:01 am Purchase | 13G | YIELD10 BIOSCIENCE INC. YTEN | HIRSCHMAN ORIN | 300,000 9% | 300,000 (New Position) | View |
2021-01-12 06:42 am Purchase | 13G | FRANKLIN WIRELESS CORP. FKWL | HIRSCHMAN ORIN | 780,000 6.8% | 780,000 (New Position) | View |
2020-12-28 4:57 pm Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | HIRSCHMAN ORIN | 1,173,230 4% | -826,770 (-41.34%) | View |
2020-12-28 06:11 am Purchase | 13G | LIGHTPATH TECHNOLOGIES INC LPTH | HIRSCHMAN ORIN | 1,834,131 7% | 1,834,131 (New Position) | View |
2020-12-28 06:10 am Purchase | 13G | EMCORE CORP EMKR | HIRSCHMAN ORIN | 1,979,013 6.7% | 1,979,013 (New Position) | View |
2020-12-17 08:11 am Purchase | 13G | CYCLO THERAPEUTICS INC CYTH | HIRSCHMAN ORIN | 418,000 9.9% | 418,000 (New Position) | View |
2020-12-14 07:15 am Sale | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | HIRSCHMAN ORIN | 190,000 1.5% | -746,735 (-79.72%) | View |
2020-12-09 06:49 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | HIRSCHMAN ORIN | 2,000,000 6.9% | 2,000,000 (New Position) | View |
2020-12-04 06:16 am Purchase | 13G | MYOMO INC. MYO | HIRSCHMAN ORIN | 416,059 9.1% | 416,059 (New Position) | View |
2020-11-27 2:30 pm Purchase | 13G | APTEVO THERAPEUTICS INC PA APVO | HIRSCHMAN ORIN | 122,165 2.95% | 122,165 (New Position) | View |
2020-11-19 06:44 am Sale | 13G | EVERSPIN TECHNOLOGIES INC MRAM | HIRSCHMAN ORIN | 354,897 11% | -595,103 (-62.64%) | View |
2020-11-06 07:25 am Purchase | 13G | O2MICRO INTERNATIONAL LTD OIIM | HIRSCHMAN ORIN | 1,828,199 6.8% | 1,828,199 (New Position) | View |
2020-09-17 07:43 am Sale | 13G | TETRA TECHNOLOGIES INC TTI | HIRSCHMAN ORIN | 3,563,342 2.83% | -3,194,387 (-47.27%) | View |
2020-08-25 09:02 am Purchase | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | HIRSCHMAN ORIN | 936,735 9.9% | 936,735 (New Position) | View |